NKESE WILLIAMS-HAYES: Open Payments
NPI 1013625177 · HOPEWELL, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,619 in 110 payments from 9 companies in 2025. Trend: 2023 $1,231 · 2024 $2,647 · 2025 $11,619
Speaker / faculty: $9,000Food & beverage: $2,505Travel & lodging: $114
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $9,597 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 29 | $830 |
| Vanda Pharmaceuticals Inc. | 13 | $317 |
| Supernus Pharmaceuticals, Inc. | 16 | $298 |
| Teva Pharmaceuticals USA, Inc. | 8 | $236 |
| Otsuka America Pharmaceutical, Inc. | 6 | $156 |
| Lundbeck LLC | 3 | $85 |
| Neurocrine BioSciences, Inc. | 1 | $80 |
| Indivior Inc. | 1 | $22 |
Products named: VRAYLAR, CAPLYTA, FANAPT, Qelbree, REXULTI, AUSTEDO XR, UZEDY, INGREZZA.
Industry payments across VA — which companies pay providers there.
